- Open Access
Potential metabolic mechanism of girls' central precocious puberty: a network analysis on urine metabonomics data
- Linlin Yang†1, 2,
- Kailin Tang†2,
- Ying Qi3,
- Hao Ye2, 4,
- Wenlian Chen5,
- Yongyu Zhang3Email author and
- Zhiwei Cao1, 2, 6Email author
© Yang et al.; licensee BioMed Central Ltd. 2012
- Published: 17 December 2012
Central precocious puberty (CPP) is a common pediatric endocrine disease caused by early activation of hypothalamic-putuitary-gonadal (HPG) axis, yet the exact mechanism was poorly understood. Although there were some proofs that an altered metabolic profile was involved in CPP, interpreting the biological implications at a systematic level is still in pressing need. To gain a systematic understanding of the biological implications, this paper analyzed the CPP differential urine metabolites from a network point of view.
In this study, differential urine metabolites between CPP girls and age-matched normal ones were identified by LC-MS. Their basic topological parameters were calculated in the background network. The network decomposition suggested that CPP differential urine metabolites were most relevant to amino acid metabolism. Further proximity analysis of CPP differential urine metabolites and neuro-endocrine metabolites showed a close relationship between CPP metabolism and neuro-endocrine system. Then the core metabolic network of CPP was successfully constructed among all these differential urine metabolites. As can be demonstrated in the core network, abnormal aromatic amino acid metabolism might influence the activity of HPG and hypothalamic pituitary adrenal (HPA) axis. Several adjustments to the early activation of puberty in CPP girls could also be revealed by urine metabonomics.
The present article demonstrated the ability of urine metabonomics to provide several potential metabolic clues for CPP's mechanism. It was revealed that abnormal metabolism of amino acid, especially aromatic amino acid, might have a close correlation with CPP's pathogenesis by activating HPG axis and suppressing HPA axis. Such a method of network-based analysis could also be applied to other metabonomics analysis to provide an overall perspective at a systematic level.
- Metabolic Network
- Hypothalamic Pituitary Adrenal Axis
- Central Precocious Puberty
- Background Network
Central precocious puberty (CPP) is defined as the emergence of secondary sexual characteristics before the age of 8 in girls and 9 in boys due to the early activation of the hypothalamic-putuitary-gonadal (HPG) axis . With an incidence of 1/5000 to 1/10000, which is higher in girls, CPP has become one of the most common pediatric endocrine diseases causing physiological and psychological difficulties for kids . Physical development is a process at an overall and systematic level while the exact pathogenesis of CPP remains unknown. Some researchers found that KISS1 and GPR54 might be relevant to CPP [3, 4]. There are also some proofs indicating a changed metabolic profile during puberty . Recently, Jia et al. have detected a urinary metabolic signature in CPP girls by using GC/LC-MS and three pathways including catecholamine metabolic pathway, tryptophan metabolic pathway and TCA cycle were identified to be altered in CPP girls . Since puberty is sensitive to metabolic cues, investigating CPP from a metabolic perspective is necessary in the way to explore its mechanism .
As a branch of systems biology, metabonomics or metabolomics is becoming a powerful platform providing a systematic, rapid and precise analysis of all the metabolites in biological materials . Many high-throughput technologies such as GC-MS, LC-MS and NMR have been successfully used for a variety of applications including biomarker identification, drug development and disease diagnosis . A general pipeline for metabonomics analysis is using the aligned spectral data combined with multivariate statistics such as PCA, OPLS or logistic regression . In this way statistically different features could be selected and subsequently identified as compounds. These technologies and analysis methods have shown their power to detect a comprehensive metabolic profile . Further biological understanding of metabonomics data is still waiting for systematic analysis by bioinformation technology .
Mapping metabolites into several distinct pathways has become a popular way in many fields including CPP research . It is known that metabolites are generally organized into a complex metabolic network more than single pathways to perform their physiological function . Some researchers have proposed several metabolomic correlation approaches, by which a putative metabolic network could be constructed [14, 15]. There are also some researchers committing to analysis based on a real metabolic network . For example, Zhao et al. found that metabolic functions were carried out in an ordered and modular way and the topological features of metabolic network could provide a functional implication . These in silico network-based analysis methods are expected to be helpful to interpret the biological understanding if applied to metabonomics data.
Here, we analyzed 76 urinary samples from CPP girls compared to 106 controls by LC-MS. Differential urine metabolites between CPP and normal girls were identified and their basic topological parameters were calculated. A functional analysis including network decomposition and enrichment analysis was performed as well. This paper focused on analyzing the CPP's differential urine metabolites at a systematic level. The biological implication was tried to be interpreted in association with known CPP pathogenesis.
Subject selection and sampling
A total of 230 Chinese girls with age of 5-10 were enrolled in this study. 86 of them were diagnosed with CPP by Children's Hospital of Shanghai Jiao Tong University (Shanghai, P. R. China) and the other 144 were volunteers as age-matched healthy control. The use of these subjects was approved by the hospital's Ethics Committee and all participants provided their informed consent. Early-morning urinary samples from each individual were collected and immediately stored at -80°C after centrifugation for further analysis. Respectively, 10 and 38 samples in CPP and control group were analyzed for other reasearches. Thus 76 CPP samples and 106 healthy ones were subsequently analyzed as follow.
Identifying differential metabolites between CPP and control
All the urinary samples were prepared and processed using the UPLC-QTOF-MS as previously described . The acquired raw data files were analyzed by the MarkerLynx application manager version 4.1 for peak detection and alignment, parameters of which were set as formerly reported . Peak normalization to total area for each sample was used as well. Furthermore, supervised OPLS-DA method was performed between CPP and control group to select the statistically different variations (VIP > 1) which were further validated as metabolites.
Generating human metabolic network
Here we constructed a human global metabolic network based on KEGG database as our background network . Below is a rough description of reconstruction. There are 4391 reactions that could happen in human body including 3057 enzyme-catalyzed reactions and 1334 autocatalytic ones in KEGG. The file named "reaction_mapformula.lst" in KEGG contains information of the actual direction of those reactions according to the involved pathways. In this way we excluded the currency metabolites and the reactions that unlikely happen in human body. The obtained substrates and products were afterwards connected into a directed network which contained 3114 nodes and 4642 arcs.
In a network, centralities of a node, including degree, betweeness and closeness, are used to measure its contribution to the communication between other nodes. Connectivity and distance, both belonging to proximities, are designed to measure how closely the nodes are connected and how far they are away from each other, respectively. All these parameters were introduced in this paper to explore the functional characteristics of CPP's differential metabolites in global metabolic network (see Additional file 1).
Z-score (see Additional file 1) is designed to evaluate whether a topological feature of CPP differential urinary metabolites is significantly different from its corresponding randomizations. Generally, a topological feature is accepted to have a statistical significance if |Z| > 2.33.
In this paper, p-value is defined by the hypergeometric cumulative distribution function (see Additional file 1). It represents the chance that at least k CPP metabolites co-exist in the same module, cluster or pathway. A cutoff of P < 0.05 means that a pathway or cluster is enriched by CPP differential urine metabolites.
Aiming to divide the whole graph into several functional areas, the constructed human metabolic network was broken up by simulated annealing algorithm, which helps to get a nearly best decomposition with the maximum modularity [20, 21]. The most connected part of the background network was extracted by removing the isolated subset (IS) of the bow-tie structure. Then it was decomposed into several modules, which were subsequently expanded to larger modules respectively. There are a few rules for expanding: (i) a node will be assigned to the module which it directly connected with; (ii) if a node is attached to several modules, it will be assigned to the module with more nodes directly connected with it; (iii) this process ends when there are no more nodes that could be added to any module.
Considering that the obtained modules may fail to have a distinct function and the CPP differential urine metabolites also might be too much distracted, a step of clustering was followed. This step of clustering was processed by Ward algorithm performed in R based on the Euclidean distances between any two modules (E i, j , see Additional file 1) .
Centralities of CPP differential urine metabolites
Totally, 99 distinct CPP differential urine metabolites were obtained by comparing CPP and normal girls' metabolic profiles identified by LC-MS. To explore these metabolites' internal connection, we mapped them in the global human metabolic network. Among the 99, 71 were annotated by KEGG database, and 49 were connected in our constructed global human metabolic network. The centralities of these 49 metabolites were investigated in the background network.
Centralities of CPP differential urine metabolites.
As can be seen in Table 1, CPP differential urine metabolites were shown to have significantly higher degree, betweeness and closeness comparing to the corresponding randomizations (|Z| > 2.33). As the degree of a node measures how many other nodes it may connect with, the higher in- and out- degree shown in Table 1 indicates that CPP differential metabolites tend to be located in the hubs of the network. This was subsequently confirmed by the following bow-tie structure analysis that revealed CPP metabolites were enriched in the giant strong component (see Additional file 2) which was the most connected part in the network. Closeness (in or out) is a metric representing the independence and efficiency of a node in communication. And betweeness represents the potential of a node for controlling information exchanging in the network. The higher closeness and betweeness shown in Table 1 suggested that those CPP differential metabolites may be critical to the communication between other metabolites in the network. Overall, these parameters of centrality including degree, closeness and betweeness all indicated an important role of CPP differential urine metabolites in the human metabolic network.
Enriched functional modules
To interpret the biological functions of CPP's metabolic clues, the enriched functions of CPP differential urine metabolites were analyzed in the background of human metabolic network extracted from KEGG. Two aspects were involved: primary metabolism and neuro-endocrine system. The former focused on primary metabolic function and the latter investigated the physiological function in CPP.
Enriched primary metabolic module
Main function of each cluster and corresponding enrichment of CPP differential urine metabolites.
CPP differential urine metabolites
Largely unknown containing partial amino acid metabolism
Metabolism of Cofactors and Vitamins
Xenobiotics Biodegradation and Metabolism
Amino Acid Metabolism
Correlation with neuro-endocrine system
CPP is widely accepted as an endocrine disorder caused by early activation of HPG axis which belongs to the neuro-endocrine-immune (NEI) system. Thus whether the CPP differential urine metabolites may correlate with the NEI system was examined by calculating their proximity. NEI interaction has been acknowledged as the main regulatory component in host's homeostasis since it was put forward in 1977 . Database of dbNEI has provided a molecular resource ranging from compounds, peptides to proteins for the NEI system [25, 26]. A total of 356 KEGG-annotated metabolites were collected from dbNEI and their proximity to those CPP metabolites was calculated in the background network. Since there was no immune metabolite in our background network, only the proximity between metabolites involved in CPP and neuro-endocrine system could be computed. As control for CPP, 105 randomizations were generated by randomly selecting 49 nodes from the background network. CPP differential urine metabolites were found to have a higher connectivity and lower distance to neuro-endocrine metabolites than the commensurable randomizations (both |Z| > 2.33, see Additional file 3). This suggested that CPP differential urine metabolites tended to have a more tight connection to neuro-endocrine system comparing to the random control.
Core metabolic network of CPP
Constructing the core network of CPP differential urine metabolites
Enriched pathways of CPP differential urine metabolites
Total metabolites in pathway
CPP differential urine metabolites in pathway
Taurine and hypotaurine metabolism
Alanine, aspartate and glutamate metabolism
Arginine and proline metabolism
Perturbation of Neurotransmitters and Neuroactive Metabolites
As can be found in Figure 3, although the network was constructed mainly based on CPP unrine metabolites, many compounds (12 among 40) were neurotransmitters or neuroactive metabolites. The 9 neurotransmitters highlighted in yellow include epinephrine, norepinephrine, serontonin, cysteine, taurine, alanine, glutamic acid, aspartate and GABA. And four (4/9) of them were found to be differentially expressed in CPP and the others were all closely related to the CPP differential urine metabolites. A similar situation also exists in the 3 neuroactive metabolites, as being highlighted in green. One of them, taurocyamine, a inhibitor for taurine transportion and also a antagonist for glycine receptor, was directly interfered in CPP . The other two, kynurenate and quinilnate, were one- or two- step away from CPP differential metabolites. Kynurenate is an extensive antagonist for excitatory amino acid receptors , and quinilnate has been reported with a potential toxicity in some neurodegenetative diseases . Despite of the observation, further CPP pathogenesis and the relationship between cause and effect might be worthy of validation.
Upstream of HPG axis and HPA axis
As Figure 3 shows, upstream of the HPG and HPA axis is the metabolism of aromatic amino acids. There were two main pathways: tyrosine metabolism and tryptophan metabolism.
This pathway was shown in box A of Figure 3. It has been reported that epinephrine can stimulate the activation of HPA axis while the HPA axis could inhibit female reproduction at multi-levels [32, 33]. As can be seen in Box A, epinephrine was found to be down-regulated in CPP patients, indicating a decreased activation of HPA axis and further switching on the initiation of female reproduction. By the way, HPA axis in females was reported to be more sensitive than that in males . This could be one of the reasons why girls are more incident to CPP than boys.
Secondly, hordenine could accelerate the secretion of norepinephrine . Then norepinephrine could facilitate hypothalamic cells to secrete gonadotropin-releasing hormone (GnRH) which could directly activate the HPG axis and subsequently promote the development of reproduction system . In this study, hordenine was detected to be up-regulated in the CPP urine samples and may finally promote the sex hormone secretion with norepinephrine as a media.
Furthermore, vanylglycol can be regarded as a reflection of the excitement of the noradrenergic neurons in CNS and sympathetic nervous system . The significant up-regulation of vanylglycol in CPP urine group might suggest a more active state of patients' neuro-endocrine system than normal ones.
This pathway was represented in box B of Figure 3. In this pathway, serotonin could suppress HPG axis and activate HPA axis by exciting the corticotrophin-releasing hormone (CRH) neuron . Although serotonin was not directly detected as CPP differential metabolites in this study, several related metabolites could provide some clues. In CPP girls' urine samples, the precursor of serotonin, 5-hydroxy-tryptophan, was detected to be down-regulated while the terminal products of serotonin, 5-hydroxyindoleacetic acid and 5-hydroxyindoleacetylglycine, was recognized to be up-regulated. But this evidence was not strong enough to infer serotonin's level in CPP girls. More directly, the concentration of 5-methoxytryptophan (ML) was reported to be consistent with serotonin in human body and ML was identified to be down-regulated in CPP group in this study . The diminished ML may imply a lower level of serotonin and further contribute to the activation of HPG axis and suppression of HPA axis.
Downstream of HPG axis and HPA axis
As Figure 3 shows, downstream of the HPG and HPA axis is mainly proline metabolism and pyrimidine metabolism. Proline and hydroxyproline are essential components for collagen. In box C of Figure 3, the high urine concentrations of proline and hydroxyproline in CPP girls could indicate the need for skeleton development during puberty. In pyrimidine catabolism (box F), DNA synthesis was enhanced whereas DNA degradation was weakened. A resulting accumulated amount of DNA could be used for the cell proliferation in the basic development in CPP girls. There were also some other adjustments to the precocious puberty. For example, epinephrine can not only regulate the nervous system as a neurotransmitter but also stimulate the lipolysis . Accordingly, the CPP's lower level of epinephrine might contribute to the higher body mass index (BWI) of CPP girls (p ≪ 0.01, one-tailed Wilcoxon test).
In this study, the potential metabolic mechanism of CPP was tried to be interpreted by a network analysis method to the urine metabonomics data at a systematic level. A core network of CPP differential urine metabolites was also generated as a comprehensive graph. Our results demonstrated that (i) Abnormal amino acid metabolism might be most relevant to CPP based on the urine metabolite profile; (ii) The urine metabolic profile of CPP girls could reflect the abnormal activity of neuro-endocrine system; (iii) Specifically, aromatic amino acid metabolism might contribute to CPP pathogenesis by activating HPG axis and suppressing HPA axis; and (iv) Several adjustments to the early activation of puberty in CPP girls could also be revealed by urine metabonomics. The network analysis method in this study could also be applied to further biological implications interpreting from metabonomics data by providing an overall perspectives at the systematic level.
This work was supported in part by grants from Ministry of Science and Technology China (2012ZX10005001), National Natural Science Foundation of China (30672636, 30900832, 31171272).
This article has been published as part of BMC Systems Biology Volume 6 Supplement 3, 2012: Proceedings of The International Conference on Intelligent Biology and Medicine (ICIBM) - Systems Biology. The full contents of the supplement are available online at http://www.biomedcentral.com/bmcsystbiol/supplements/6/S3.
- Krysiak R, Marek B, Okopien B: Central precocious puberty. Endokrynol Pol. 2008, 59: 530-540.PubMedGoogle Scholar
- Partsch CJ, Sippell WG: Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update. 2001, 7: 292-302. 10.1093/humupd/7.3.292.View ArticlePubMedGoogle Scholar
- Luan X, Zhou Y, Wang W, Yu H, Li P, Gan X, Wei D, Xiao J: Association study of the polymorphisms in the KISS1 gene with central precocious puberty in Chinese girls. Eur J Endocrinol. 2007, 157: 113-118. 10.1530/EJE-07-0061.View ArticlePubMedGoogle Scholar
- Luan X, Yu H, Wei X, Zhou Y, Wang W, Li P, Gan X, Wei D, Xiao J: GPR54 polymorphisms in Chinese girls with central precocious puberty. Neuroendocrinology. 2007, 86: 77-83. 10.1159/000107511.View ArticlePubMedGoogle Scholar
- Ilich JZ, Badenhop NE, Jelic T, Clairmont AC, Nagode LA, Matkovic V: Calcitriol and bone mass accumulation in females during puberty. Calcif Tissue Int. 1997, 61: 104-109. 10.1007/s002239900304.View ArticlePubMedGoogle Scholar
- Qi Y, Li P, Zhang Y, Cui L, Guo Z, Xie G, Su M, Li X, Zheng X, Qiu Y, Liu Y, Zhao A, Jia W: Urinary metabolite markers of precocious puberty. Mol Cell Proteomics. 2012, 11: M111.011072-10.1074/mcp.M111.011072.PubMed CentralView ArticlePubMedGoogle Scholar
- Roa J, Garcia-Galiano D, Castellano JM, Gaytan F, Pinilla L, Tena-Sempere M: Metabolic control of puberty onset: new players, new mechanisms. Mol Cell Endocrinol. 2010, 324: 87-94. 10.1016/j.mce.2009.12.018.View ArticlePubMedGoogle Scholar
- Weckwerth W: Metabolomics: an integral technique in systems biology. Bioanalysis. 2010, 2: 829-836. 10.4155/bio.09.192.View ArticlePubMedGoogle Scholar
- Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK: Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers. 2004, 9: 1-31. 10.1080/13547500410001668379.View ArticlePubMedGoogle Scholar
- Suhre K, Shin S-Y, Petersen A-K, Mohney RP, Meredith D, Wägele B, Altmaier E, CardioGram , Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes H-W, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Erich Wichmann H, Zhai G, Illig T: Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011, 477: 54-60. 10.1038/nature10354.View ArticlePubMedGoogle Scholar
- Plumb RS, Stumpf CL, Gorenstein MV, Castro-Perez JM, Dear GJ, Anthony M, Sweatman BC, Connor SC, Haselden JN: Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Communications in Mass Spectrometry. 2002, 16: 1991-1996. 10.1002/rcm.813.View ArticlePubMedGoogle Scholar
- Shulaev V: Metabolomics technology and bioinformatics. Brief Bioinform. 2006, 7: 128-139. 10.1093/bib/bbl012.View ArticlePubMedGoogle Scholar
- Zhao J, Yu H, Luo J, Cao ZW, Li Y: Complex networks theory for analyzing metabolic networks. Chinese Science Bulletin. 2006, 51: 1529-1537. 10.1007/s11434-006-2015-2.View ArticleGoogle Scholar
- Fukushima A, Kusano M, Redestig H, Arita M, Saito K: Metabolomic correlation-network modules in Arabidopsis based on a graph-clustering approach. BMC Syst Biol. 2011, 5: 1-10.1186/1752-0509-5-1.PubMed CentralView ArticlePubMedGoogle Scholar
- Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ: Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Systems Biology. 2011, 5: 21-10.1186/1752-0509-5-21.PubMed CentralView ArticlePubMedGoogle Scholar
- Cottret L, Wildridge D, Vinson F, Barrett MP, Charles H, Sagot MF, Jourdan F: MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks. Nucleic Acids Res. 2010, 38: W132-137. 10.1093/nar/gkq312.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhao J, Geng C, Tao L, Zhang D, Jiang Y, Tang K, Zhu R, Yu H, Zhang W, He F, Li Y, Cao Z: Reconstruction and analysis of human liver-specific metabolic network based on CNHLPP data. J Proteome Res. 2010, 9: 1648-1658. 10.1021/pr9006188.View ArticlePubMedGoogle Scholar
- Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Xu LX, Yen Y, Liu P, Jia W: Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics. 2011, 10: M110 004945-PubMed CentralView ArticlePubMedGoogle Scholar
- Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093/nar/28.1.27.PubMed CentralView ArticlePubMedGoogle Scholar
- Guimera R, Amaral LA: Cartography of complex networks: modules and universal roles. J Stat Mech. 2005, 2005: nihpa35573-View ArticlePubMedGoogle Scholar
- Guimerà R, Amaral LAN: Functional cartography of complex metabolic networks. Nature. 2005, 433: 895-900. 10.1038/nature03288.PubMed CentralView ArticlePubMedGoogle Scholar
- The R Project for Statistical Computing. [http://www.R-project.org]
- Networks/Pajek Program for Large Network Analysis. [http://vlado.fmf.uni-lj.si/pub/networks/pajek/]
- Besedovsky H, Sorkin E: Network of immune-neuroendocrine interactions. Clin Exp Immunol. 1977, 27: 1-12.PubMed CentralPubMedGoogle Scholar
- Zhuang Y, Li S, Li Y: dbNEI: a specific database for neuro-endocrine-immune interactions. Neuro Endocrinol Lett. 2006, 27: 53-59.PubMedGoogle Scholar
- Zhang J, Ma T, Li Y, Li S: dbNEI2.0: building multilayer network for drug-NEI-disease. Bioinformatics. 2008, 24: 2409-2411. 10.1093/bioinformatics/btn388.View ArticlePubMedGoogle Scholar
- Brann DW, Mahesh VB: Excitatory amino acids: evidence for a role in the control of reproduction and anterior pituitary hormone secretion. Endocr Rev. 1997, 18: 678-700. 10.1210/er.18.5.678.PubMedGoogle Scholar
- Magiakou MA, Mastorakos G, Webster E, Chrousos GP: The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann N Y Acad Sci. 1997, 816: 42-56. 10.1111/j.1749-6632.1997.tb52128.x.View ArticlePubMedGoogle Scholar
- Sergeeva OA, Chepkova AN, Haas HL: Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum. Br J Pharmacol. 2002, 137: 855-860. 10.1038/sj.bjp.0704940.PubMed CentralView ArticlePubMedGoogle Scholar
- Birch PJ, Grossman CJ, Hayes AG: Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol. 1988, 151: 313-315. 10.1016/0014-2999(88)90814-X.View ArticlePubMedGoogle Scholar
- Pawlak D, Tankiewicz A, Buczko W: Kynurenine and its metabolites in the rat with experimental renal insufficiency. J Physiol Pharmacol. 2001, 52: 755-766.PubMedGoogle Scholar
- Tsigos C, Chrousos GP: Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002, 53: 865-871. 10.1016/S0022-3999(02)00429-4.View ArticlePubMedGoogle Scholar
- Chrousos GP: Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci. 1998, 851: 311-335. 10.1111/j.1749-6632.1998.tb09006.x.View ArticlePubMedGoogle Scholar
- Chrousos GP, Torpy DJ, Gold PW: Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med. 1998, 129: 229-240.View ArticlePubMedGoogle Scholar
- Hapke HJ, Strathmann W: Pharmacological effects of hordenine. Dtsch Tierarztl Wochenschr. 1995, 102: 228-232.PubMedGoogle Scholar
- Herrmann N, Lanctot KL, Khan LR: The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2004, 16: 261-276. 10.1176/appi.neuropsych.16.3.261.View ArticlePubMedGoogle Scholar
- Skene DJ, Vivien-Roels B, Sparks DL, Hunsaker JC, Pevet P, Ravid D, Swaab DF: Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res. 1990, 528: 170-174. 10.1016/0006-8993(90)90214-V.View ArticlePubMedGoogle Scholar
- Berecek KH, Brody MJ: Evidence for a neurotransmitter role for epinephrine derived from the adrenal medulla. Am J Physiol. 1982, 242: H593-601.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.